A patient who is losing slowly but maintaining muscle, eating enough protein, and improving blood sugar may be making meaningful progress
Tirzepatide (mounjaro) activates both GIP and GLP-1 receptors, rather than GLP-1 alone
Abstract Introduction Type 2 diabetes mellitus (T2DM) is a complex metabolic disease with several treatment options
Ozempic (semaglutide) has transformed diabetes care and weight management, offering proven improvements in blood sugar control and meaningful weight loss for many patients
For at least 48 hours, patients should use gentle, non-irritating skincare products and steer clear of exfoliating ingredients like retinol, alpha hydroxy acids (AHAs), and beta hydroxy acids (BHAs)
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial